润达医疗2月25日获融资买入6707.20万元，融资余额6.26亿元

Group 1 - The core viewpoint of the news is that RunDa Medical has experienced fluctuations in its stock performance and financial metrics, indicating potential investment opportunities and risks [1][2][3] Group 2 - On February 25, RunDa Medical's stock rose by 3.79%, with a trading volume of 700 million yuan. The financing buy-in amount for the day was 67.07 million yuan, while the financing repayment was 58.99 million yuan, resulting in a net financing buy-in of 8.07 million yuan [1] - As of February 25, the total balance of margin trading for RunDa Medical was 629 million yuan, with the financing balance accounting for 6.31% of the circulating market value, indicating a high level compared to the past year [1] - The company reported a total revenue of 5.268 billion yuan for the period from January to September 2025, reflecting a year-on-year decrease of 14.70%, and a net profit attributable to shareholders of -163 million yuan, a significant decline of 422.64% [2] - RunDa Medical has distributed a total of 373 million yuan in dividends since its A-share listing, with 165 million yuan distributed in the last three years [3] - As of September 30, 2025, the number of shareholders for RunDa Medical was 64,800, a decrease of 1.05% from the previous period, while the average circulating shares per person increased by 1.06% to 9,317 shares [2][3]